HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ONO-1603, a potential antidementia drug, shows neuroprotective effects and increases m3-muscarinic receptor mRNA levels in differentiating rat cerebellar granule neurons.

Abstract
We have reported that the antidementia drug tetrahydroaminoacridine (THA; 30 microM) is neuroprotective and neurotrophic and selectively increases m3-muscarinic acetylcholine receptor (mAChR) mRNA levels in differentiating cerebellar granule cells. Here, we examined whether novel prolyl endopeptidase inhibitor ONO-1603, a potential antidementia drug, induces similar effects in these cerebellar neurons. Supplement of ONO-1603 (0.03 microM) to cultures grown in 15 mM KCl-containing media was found to markedly promote neuronal survival and neurite outgrowth and enhance [3H]N-methylscopolamine binding to mAChRs. Moreover, ONO-1603 increased the level of m3-mAChR mRNA and stimulated mAChR-mediated phosphoinositide turnover. The common actions of ONO-1603 and THA suggest that these properties could be related to their putative antidementia activities and that this model system may be used to screen for drugs effective in the treatment for Alzheimer's disease.
AuthorsN Katsube, K Sunaga, D M Chuang, R Ishitani
JournalNeuroscience letters (Neurosci Lett) Vol. 214 Issue 2-3 Pg. 151-4 (Aug 23 1996) ISSN: 0304-3940 [Print] Ireland
PMID8878106 (Publication Type: Journal Article)
Chemical References
  • Cholinesterase Inhibitors
  • Muscarinic Agonists
  • Neuroprotective Agents
  • ONO 1603
  • Phosphatidylinositols
  • Pyrrolidines
  • RNA, Messenger
  • Receptors, Muscarinic
  • Serine Proteinase Inhibitors
  • Physostigmine
  • Serine Endopeptidases
  • Prolyl Oligopeptidases
Topics
  • Animals
  • Brain Edema (drug therapy)
  • Cell Differentiation (drug effects)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Cerebellum (cytology, drug effects)
  • Cholinesterase Inhibitors (pharmacology)
  • Muscarinic Agonists (pharmacology)
  • Neurons (drug effects)
  • Neuroprotective Agents (pharmacology)
  • Phosphatidylinositols (metabolism)
  • Physostigmine (pharmacology)
  • Prolyl Oligopeptidases
  • Pyrrolidines (pharmacology)
  • RNA, Messenger (biosynthesis)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Muscarinic (biosynthesis, metabolism)
  • Serine Endopeptidases (metabolism)
  • Serine Proteinase Inhibitors (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: